未找到相关数据
HELICOBACTER-PYLORI BEFORE AND AFTER GASTRIC REDUCTION FOR MORBID-OBESITY
被引：8
作者：
SCAPA, E
BOLDUR, I
GLUSKIN, J
BROIDE, E
BOGOKOWSKY, H
ESHCHAR, J
机构：
[1] Institute of Gastroenterology, Liver Diseases and Nutrition, Assaf Harofeh Medical Center, Tel Aviv University, Sackler Faculty of Medicine
[2] Institute of Microbiology, Assaf Harofeh Medical Center, Sackler Faculty of Medicine, Zerifin
[3] Institute of Microbiology, Assaf Harofeh Medical Center, Tel Aviv University, Sackler Faculty of Medicine, Zerifin
[4] Institute of Gastroenterology, Liver Diseases and Nutrition, Assaf Harofeh Medical Center, Zerifin
[5] Department of Surgery ‘B’, Assaf Harofeh Medical Center, Tel Aviv University, Sackler Faculty of Medicine, Zerifin
[6] Institute of Gastroenterology, Liver Diseases and Nutrition, Assaf Harofeh Medical Center, Zerifin
[7] Tel Aviv University, Sackler Faculty of Medicine
[8] Tel Aviv University, Sackler Faculty of Medicine
[9] Tel Aviv University, Sackler Faculty of Medicine
关键词：
GASTRIC REDUCTION;
HELICOBACTER-PYLORI;
MORBID OBESITY;
D O I：
10.1381/096089292765559981
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Nine patients with morbid obesity were evaluated for the presence of Helicobacter pylori (Hp) before gastric reduction, and all were negative. Fifteen patients, including those nine, were evaluated for the presence of Hp in antral and 'channel' region biopsies by culture and urease test after gastric reduction. Hp-negative patients totalled 73.3% by both tests, although chronic superficial gastritis type 'B' was found in eight out of 13 (61.5%), and six out of seven (85.7%) gastritis patients were positive for Helicobacter-like organisms in the hematoxylin- and eosin-stained biopsies. Our data suggest that in stomachs of morbid obesity patients before as well as after gastric reduction procedures, the incidence of Hp is very low, and the reasons for this observation are yet unknown.
引用
收藏
页码：371 / 374
页数：4
相关论文